A Decade of Direct-to-Consumer Advertising of Prescription Drugs.

Donohue, J. M., Cevasco, M., & Rosenthal, M. B. (2007). A Decade of Direct-to-Consumer Advertising of Prescription Drugs. New England Journal of Medicine, 357(7), 673-681.

Type

Journal article

Intellectual base

Primary research

Year

2007

DOI

10.1056/nejmsa070502

Link

https://doi.org/10.1056/NEJMsa070502

Cited from

communication_media_studies

Cited by

1 citation across 1 artifact.

Each citation links to the sentence it supports in the citing article.

Primes

• Summary Substance Divergence
  • In drug labeling it is the front-of-package efficacy claim versus the patient leaflet — marketing optimizing the front, regulatory affairs the back.

    This sourceDocuments the marketing-authored promotional surface of drugs (DTC advertising emphasizing benefits over risks) diverging from the regulatory-authored disclosure — the front-of-package/talking-point versus leaflet/filing divergence.

Verification

This reference passed the adversarial substantiation pipeline: it was checked to exist and to support the claim it is attached to. See how references were verified.

Registry ID ref:876884d5eb2f · see in the full table